Skip to main content

FDx Advisors, Inc.

SEC CIK
0001566601
Latest filing
Aug 4, 2026

AZN holding history

AstraZeneca PLC in every 13F filed by FDx Advisors, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AZN overviewAll 13F holders of AZNFull Q2 2026 holdings

Shares (Q2 2026)
3,788
Value
$718.0K
% of portfolio
0.2%
Quarters held
21
Since Q1 2021
Holdings of AZN by FDx Advisors, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,788$718.0K0.2%−766−16.8%ReducedHolders
Q1 20264,554$898.0K0.3%−252−5.2%ReducedConverted for a 1-for-2 splitHolders
Q4 20259,611$884.0K0.5%+2,430+33.8%AddedHolders
Q3 20257,181$592.0K0.2%−356−4.7%ReducedHolders
Q2 20257,537$527.0K0.2%−3,883−34.0%ReducedHolders
Q1 202511,420$839.0K0.3%−721−5.9%ReducedHolders
Q4 202412,141$795.0K0.2%+88+0.7%AddedHolders
Q3 202412,053$939.0K0.3%−509−4.1%ReducedHolders
Q2 202412,562$980.0K0.3%−6,044−32.5%ReducedHolders
Q1 202418,606$1.26M0.2%−7,667−29.2%ReducedHolders
Q4 202326,273$1.77M0.1%−728−2.7%ReducedHolders
Q3 202327,001$1.83M0.2%−4,229−13.5%ReducedHolders
Q2 202331,230$2.23M0.1%+3,505+12.6%AddedHolders
Q1 202327,725$1.88M0.1%00.0%UnchangedHolders
Q4 202227,725$1.88M0.1%−3,509−11.2%ReducedHolders
Q3 202231,234$1.71M0.1%−2,226−6.7%ReducedHolders
Q2 202233,460$2.21M0.1%+33,460NewHolders
Q1 20220$00.0%−51,459−100.0%Sold outHolders
Q4 202151,459$3.00M0.1%−3,100−5.7%ReducedHolders
Q3 202154,559$3.28M0.1%−140−0.3%ReducedHolders
Q2 202154,699$3.28M0.1%+11,578+26.9%AddedHolders
Q1 202143,121$2.14M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.